Bulk Manufacturer of Controlled Substances Application: SpecGX, LLC, 70866 [2021-26907]

Download as PDF 70866 DATES: Federal Register / Vol. 86, No. 236 / Monday, December 13, 2021 / Notices January 6, 2022. FOR FURTHER INFORMATION CONTACT: Bridget Healy, Esq., Acting Chief Counsel, Rules Committee Staff, Administrative Office of the U.S. Courts, Thurgood Marshall Federal Judiciary Building, One Columbus Circle NE, Suite 7–300, Washington, DC 20544, Phone (202) 502–1820, RulesCommittee_Secretary@ ao.uscourts.gov. (Authority: 28 U.S.C. 2073.) Dated: December 7, 2021. Shelly L. Cox, Management Analyst, Rules Committee Staff. [FR Doc. 2021–26868 Filed 12–10–21; 8:45 am] BILLING CODE 2210–55–P DEPARTMENT OF JUSTICE Drug Enforcement Administration [Docket No. DEA–927] Importer of Controlled Substances Application: Noramco, Inc. Drug Enforcement Administration, Justice. ACTION: Notice of application. AGENCY: Noramco, Inc., has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information. DATES: Registered bulk manufacturers of the affected basic class(es), and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before January 12, 2022. Such persons may also file a written request for a hearing on the application on or before January 12, 2022. ADDRESSES: Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152. All requests for a hearing must be sent to: Drug Enforcement Administration, Attn: Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. All requests for a hearing should also be sent to: (1) Drug Enforcement Administration, Attn: Hearing Clerk/OALJ, 8701 Morrissette Drive, Springfield, Virginia 22152; and (2) Drug Enforcement Administration, Attn: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152. SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.34(a), this is notice that on September 22, 2021, khammond on DSKJM1Z7X2PROD with NOTICES SUMMARY: VerDate Sep<11>2014 16:50 Dec 10, 2021 Jkt 256001 Noramco Inc., 500 Swedes Landing Road, Wilmington, Delaware 19801– 4417, applied to be registered as an importer of the following basic class(es) of controlled substance(s): Drug code Controlled substance Marihuana ............................... Tetrahydrocannabinols ........... Nabilone .................................. Phenylacetone ........................ Opium, Raw ............................ Poppy Straw Concentrate ....... Noroxymorphone .................... Tapentadol .............................. 7360 7370 7379 8501 9600 9670 9668 9780 Schedule I I II II II II II II The company plans to import Phenylacetone (8501), and Poppy Straw Concentrate (9670) to bulk manufacture other controlled substances for distribution to its customers. The company plans to import an intermediate form of Tapentadol (9780) to bulk manufacture Tapentadol for distribution to its customers. In reference to drug codes 7360 (Marihuana) and 7370 (Tetrahydrocannabinols), the company plans to import a synthetic cannabidiol and a synthetic Tetrahydrocannabinol. No other activity for these drug codes is authorized for this registration. Approval of permit applications will occur only when the registrant’s business activity is consistent with what is authorized under 21 U.S.C. 952(a)(2). Authorization will not extend to the import of Food and Drug Administration-approved or nonapproved finished dosage forms for commercial sale. Brian S. Besser, Acting Assistant Administrator. [FR Doc. 2021–26906 Filed 12–10–21; 8:45 am] BILLING CODE P Drug Enforcement Administration [Docket No. DEA–932] Bulk Manufacturer of Controlled Substances Application: SpecGX, LLC Drug Enforcement Administration, Justice. ACTION: Notice of application. AGENCY: SpecGX, LLC, has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplemental Information listed below for further drug information. DATES: Registered bulk manufacturers of the affected basic class(es), and applicants therefore, may file written comments on or objections to the PO 00000 Frm 00053 Fmt 4703 Sfmt 4703 In accordance with 21 CFR 1301.33(a), this is notice that on September 20, 2021, SpecGX LLC, 3600 North 2nd Street, Saint Louis, Missouri 63147, applied to be registered as a bulk manufacturer of the following basic class(es) of controlled substance(s): SUPPLEMENTARY INFORMATION: Controlled substance Phenylacetone ................ Drug code Schedule 8501 II The company plans to manufacture the above-listed controlled substance in bulk for conversion to other controlled substances. No other activity for this drug code is authorized for this registration. Brian S. Besser, Acting Assistant Administrator. [FR Doc. 2021–26907 Filed 12–10–21; 8:45 am] BILLING CODE P DEPARTMENT OF LABOR Employee Benefits Security Administration Agency Information Collection Activities; Request for Public Comment Employee Benefits Security Administration (EBSA), Department of Labor. ACTION: Notice. AGENCY: DEPARTMENT OF JUSTICE SUMMARY: issuance of the proposed registration on or before February 11, 2022. Such persons may also file a written request for a hearing on the application on or before February 11, 2022. ADDRESSES: Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152. The Department of Labor (the Department), in accordance with the Paperwork Reduction Act, provides the general public and Federal agencies with an opportunity to comment on proposed and continuing collections of information. This helps the Department assess the impact of its information collection requirements and minimize the public’s reporting burden. It also helps the public understand the Department’s information collection requirements and provide the requested data in the desired format. The Employee Benefits Security Administration (EBSA) is soliciting comments on the proposed extension of SUMMARY: E:\FR\FM\13DEN1.SGM 13DEN1

Agencies

[Federal Register Volume 86, Number 236 (Monday, December 13, 2021)]
[Notices]
[Page 70866]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-26907]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-932]


Bulk Manufacturer of Controlled Substances Application: SpecGX, 
LLC

AGENCY: Drug Enforcement Administration, Justice.

ACTION: Notice of application.

-----------------------------------------------------------------------

SUMMARY: SpecGX, LLC, has applied to be registered as a bulk 
manufacturer of basic class(es) of controlled substance(s). Refer to 
Supplemental Information listed below for further drug information.

DATES: Registered bulk manufacturers of the affected basic class(es), 
and applicants therefore, may file written comments on or objections to 
the issuance of the proposed registration on or before February 11, 
2022. Such persons may also file a written request for a hearing on the 
application on or before February 11, 2022.

ADDRESSES: Written comments should be sent to: Drug Enforcement 
Administration, Attention: DEA Federal Register Representative/DPW, 
8701 Morrissette Drive, Springfield, Virginia 22152.

SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.33(a), this 
is notice that on September 20, 2021, SpecGX LLC, 3600 North 2nd 
Street, Saint Louis, Missouri 63147, applied to be registered as a bulk 
manufacturer of the following basic class(es) of controlled 
substance(s):

------------------------------------------------------------------------
                                          Drug
          Controlled substance            code           Schedule
------------------------------------------------------------------------
Phenylacetone..........................    8501  II
------------------------------------------------------------------------

    The company plans to manufacture the above-listed controlled 
substance in bulk for conversion to other controlled substances. No 
other activity for this drug code is authorized for this registration.

Brian S. Besser,
Acting Assistant Administrator.
[FR Doc. 2021-26907 Filed 12-10-21; 8:45 am]
BILLING CODE P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.